[1]
|
Kolominsky-Rabas, P.L., Weber, M., Gefeller, O., Neundoerfer, B. and Heuschmann, P.U. (2001) Epidemiology of Ischemic Stroke Subtypes According to TOAST Criteria: Incidence, Recurrence, and Long-Term Survival in Ischemic Stroke Subtypes: A Population-Based Study. Stroke, 32, 2735-2740. https://doi.org/10.1161/hs1201.100209
|
[2]
|
Marini, C., De Santis, F., Sacco, S., Russo, T., Olivieri, L., Totaro, R., et al. (2005) Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke: Results from a Population-Based Study. Stroke, 36, 1115-1119.
https://doi.org/10.1161/01.STR.0000166053.83476.4a
|
[3]
|
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J.J., Blomström-Lundqvist, C., et al. (2020) 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). European Heart Journal, ehaa612.
https://doi.org/10.1093/eurheartj/ehaa612
|
[4]
|
Rost, N.S., Biffi, A., Cloonan, L., Chorba, J., Kelly, P., Greer, D., et al. (2012) Brain Natriuretic Peptide Predicts Functional Outcome in Ischemic Stroke. Stroke, 43, 441-445.
https://doi.org/10.1161/STROKEAHA.111.629212
|
[5]
|
Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., et al. (1991) Brain Natriuretic Peptide as a Novel Cardiac Hormone in Humans. Evidence for an Exquisite Dual Natriuretic Peptide System, Atrial Natriuretic Peptide and Brain Natriuretic Peptide. Journal of Clinical Investigation, 87, 1402-1412.
https://doi.org/10.1172/JCI115146
|
[6]
|
Maeda, K., Tsutamoto, T., Wada, A., Hisanaga, T. and Hisanaga, T. (1998) Plasma Brain Natriuretic Peptide as a Biochemical Marker of High Left Ventricular End-Diastolic Pressure in Patients with Symptomatic Left Ventricular Dysfunction. American Heart Journal, 135, 825-832. https://doi.org/10.1016/S0002-8703(98)70041-9
|
[7]
|
Sakamoto, Y., Suda, S., Matsumoto, N., Aoki, J., Shimoyama, T., Kanamaru, T., et al. (2019) Accurate Etiology Diagnosis in Patients with Stroke and Atrial Fibrillation: A Role for Brain Natriuretic Peptide. Journal of the Neurological Sciences, 400, 153-157. https://doi.org/10.1016/j.jns.2019.03.031
|
[8]
|
Tuinenburg, A.E., Brundel, B.J., Van Gelder, I.C., Henning, R.H., Van Den Berg, M.P., Driessen, C., et al. (1999) Gene Expression of the Natriuretic Peptide System in Atrial Tissue of Patients with Paroxysmal and Persistent Atrial Fibrillation. Journal of Cardiovascular Electrophysiology, 10, 827-835.
|
[9]
|
Stanciu, A.E., Vatasescu, R.G., Stanciu, M.M., Serdarevic, N. and Dorobantu, M. (2018) The Role of Pro-Fibrotic Biomarkers in Paroxysmal and Persistent Atrial Fibrillation. Cytokine, 103, 63-68.
https://doi.org/10.1016/j.cyto.2017.12.026
|
[10]
|
Pathan, F., Sivaraj, E., Negishi, K., Rafiudeen, R., Pathan, S., D’Elia, N., et al. (2018) Use of Atrial Strain to Predict Atrial Fibrillation after Cerebral Ischemia. JACC: Cardiovascular Imaging, 11, 1557-1565.
https://doi.org/10.1016/j.jcmg.2017.07.027
|
[11]
|
Padfield, G.J., Steinberg, C., Swampillai, J., Qian, H., Connolly, S.J., Dorian, P., et al. (2017) Progression of Paroxysmal to Persistent Atrial Fibrillation: 10-Year Follow-Up in the Canadian Registry of Atrial Fibrillation. Heart Rhythm, 14, 801-807. https://doi.org/10.1016/j.hrthm.2017.01.038
|
[12]
|
Conen, D., Rodondi, N., Müller, A., Beer, J.H., Ammann, P., Moschovitis, G., et al. (2019) Relationships of Overt and Silent Brain Lesions with Cognitive Function in Patients with Atrial Fibrillation. Journal of the American College of Cardiology, 73, 989-999. https://doi.org/10.1016/j.jacc.2018.12.039
|
[13]
|
Amarenco, P., Bogousslavsky, J., Caplan, L.R., Donnan, G.A. and Hennerici, M.G. (2009) New Approach to Stroke Subtyping: The A-S-C-O (Phenotypic) Classification of Stroke. Cerebrovascular Diseases, 27, 502-508.
https://doi.org/10.1159/000210433
|
[14]
|
Sanna, T., Diener, H.-C., Passman, R.S., Di Lazzaro, V., Bernstein, R.A., Morillo, C.A., et al. (2014) Cryptogenic Stroke and Underlying Atrial Fibrillation. New England Journal of Medicine, 370, 2478-2486.
|
[15]
|
Inaba, O., Yamauchi, Y., Sekigawa, M., Miwa, N., Yamaguchi, J., Nagata, Y., et al. (2018) Atrial Fibrillation Type Matters: Greater Infarct Volume and Worse Neurological Defects Seen in Acute Cardiogenic Cerebral Embolism Due to Persistent or Permanent Rather than Paroxysmal Atrial Fibrillation. EP Europace, 20, 1591-1597.
https://doi.org/10.1093/europace/eux346
|
[16]
|
Gaita, F., Corsinovi, L., Anselmino, M., Raimondo, C., Pianelli, M., Toso, E., et al. (2013) Prevalence of Silent Cerebral Ischemia in Paroxysmal and Persistent Atrial Fibrillation and Correlation with Cognitive Function. Journal of the American College of Cardiology, 62, 1990-1997. https://doi.org/10.1016/j.jacc.2013.05.074
|
[17]
|
Hsu, J.C., Chan, P.S., Tang, F.M., Maddox, T.M. and Marcus, G.M. (2015) Differences in Anticoagulant Therapy Prescription in Patients with Paroxysmal versus Persistent Atrial Fibrillation. American Journal of Medicine, 128, 654.e1-654.e10. https://doi.org/10.1016/j.amjmed.2014.11.035
|
[18]
|
Hylek, E.M., Go, A.S., Chang, Y.C., Jensvold, N.G., Henault, L.E., Selby, J.V., et al. (2003) Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation. New England Journal of Medicine, 349, 1019-1026. https://doi.org/10.1056/NEJMoa022913
|
[19]
|
Seet, R.C., Friedman, P.A. and Rabinstein, A.A. (2011) Prolonged Rhythm Monitoring for the Detection of Occult Paroxysmal Atrial Fibrillation in Ischemic Stroke of Unknown Cause. Circulation, 124, 477-486.
https://doi.org/10.1161/CIRCULATIONAHA.111.029801
|
[20]
|
Healey, J.S., Connolly, S.J., Gold, M.R., Israel, C.W., Van Gelder, I.C., Capucci, A., et al. (2012) Subclinical Atrial Fibrillation and the Risk of Stroke. New England Journal of Medicine, 366, 120-129.
https://doi.org/10.1056/NEJMoa1105575
|
[21]
|
Olesen, J.B., Lip, G.Y.H., Hansen, M.L., Tolstrup, J.S., Lindhardsen, J., Selmer, C., et al. (2011) Validation of Risk Stratification Schemes for Predicting Stroke and Thromboembolism in Patients with Atrial Fibrillation: Nationwide Cohort study. BMJ, 342, d124. https://doi.org/10.1136/bmj.d124
|
[22]
|
Hijazi, Z., Lindbäck, J., Alexander, J.H., Hanna, M., Held, C., Hylek, E.M., et al. (2016) The ABC (Age, Biomarkers, Clinical History) Stroke Risk Score: A Biomarker-Based Risk Score for Predicting Stroke in Atrial Fibrillation. European Heart Journal, 37, 1582-1590. https://doi.org/10.1093/eurheartj/ehw054
|